Primary Graft Dysfunction after Heart Transplantation - Unravelling the Enigma.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 28 06 2021
accepted: 09 07 2021
pubmed: 19 8 2021
medline: 14 6 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

Primary graft dysfunction (PGD) remains the main cause of early mortality following heart transplantation despite several advances in donor preservation techniques and therapeutic strategies for PGD. With that aim of establishing the aetiopathogenesis of PGD and the preferred management strategies, the new consensus definition has paved the way for multiple contemporaneous studies to be undertaken and accurately compared. This review aims to provide a broad-based understanding of the pathophysiology, clinical presentation and management of PGD.

Identifiants

pubmed: 34404551
pii: S0146-2806(21)00156-0
doi: 10.1016/j.cpcardiol.2021.100941
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100941

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Ahmed Al-Adhami (A)

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow UK.

Sanjeet Singh Avtaar Singh (SS)

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow UK; Institute of Cardiovascular and Medical Sciences (ICAMS), University of Glasgow. Electronic address: sanjeet.singh@glasgow.ac.uk.

Sudeep Das De (SD)

Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.

Ramesh Singh (R)

Mechanical Circulatory Support, Inova Health System, Falls Church, Virginia.

Gurusher Panjrath (G)

Heart Failure and Mechanical Circulatory Support Program, George Washington University Hospital, Washington, DC.

Amit Shah (A)

Advanced Heart Failure and Cardiac Transplant Unit, Fiona Stanley Hospital, Perth, Australia.

Jonathan R Dalzell (JR)

Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, UK.

Jacob Schroder (J)

Heart Transplantation Program, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC.

Nawwar Al-Attar (N)

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow UK; Institute of Cardiovascular and Medical Sciences (ICAMS), University of Glasgow.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH